《美股业绩》晶片设备商应用材料季绩及盈测胜预期 市後升近4%
美国晶片设备生产商应用材料(Applied Materials)(AMAT.US)公布截至1月底止首财季业绩。季度纯利11.3亿美元,按年升27%。每股季度摊薄纯利1.22美元,经调整後为1.39美元,高於市场预期的1.28美元。季度销售额51.62亿美元,按年升24%,高於市场预期的49.7亿美元。
公司预期现财季收入介乎51.9亿至55.9亿美元,高於市场预期的49.6亿美元。经调整季度纯利预测介乎1.44至1.56美元,高於市场预期的1.28美元。
应用材料股价在延长交易时段升3.9%,报117.85美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.